These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 8962302
21. Cyclosporine Neoral in liver transplant recipients. Levy G, Rochon J, Freeman D, Wong PY, Banks L, Roach C, Engel K, Grant D. Transplant Proc; 1994 Oct; 26(5):2949-52. PubMed ID: 7940930 [No Abstract] [Full Text] [Related]
22. Neoral in liver transplantation. Levy GA, Grant D. Transplant Proc; 1996 Apr; 28(2):1019-21. PubMed ID: 8623216 [Abstract] [Full Text] [Related]
23. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients. Melter M, Rodeck B, Kardorff R, Hoyer PF, Maibücher A, Brodehl J. Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224 [No Abstract] [Full Text] [Related]
24. Conversion from Sandimmune to Neoral in stable liver graft recipients. Pollard SG, Lodge JP. Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213 [No Abstract] [Full Text] [Related]
25. Conversion from Sandimmune to Neoral in stable heart transplant recipients. Pethig K, Ruhparwar A, Korn A, Christians U, Wahlers T. Transplant Proc; 1996 Aug; 28(4):2287-9. PubMed ID: 8769228 [No Abstract] [Full Text] [Related]
26. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral. Levy GA. Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216 [No Abstract] [Full Text] [Related]
29. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral. Vathsala A, Lee WT, Jacob E, Woo KT. Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678 [No Abstract] [Full Text] [Related]
30. Cyclosporine pharmacology. Lee JI, Canafax DM. Transplant Proc; 1996 Aug; 28(4):2156-8. PubMed ID: 8769185 [No Abstract] [Full Text] [Related]
31. Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients. Tsang WK, Ho YW, Tong KL, Chan WH, Chan A. Transplant Proc; 1996 Jun; 28(3):1330-2. PubMed ID: 8658681 [No Abstract] [Full Text] [Related]
32. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients. White M, Pelletier GB, Tan A, Jesina C, Carrier M. J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770 [Abstract] [Full Text] [Related]
33. The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients. Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R, Carson R, Alexander JW, Chang C, Choc M. Transplant Proc; 1994 Oct; 26(5):2940-3. PubMed ID: 7940928 [No Abstract] [Full Text] [Related]
35. Cyclosporine pharmacokinetics in stable renal transplant patients: effect of formulation Sandimmun versus Consupren versus Neoral. Masri MA, Barbari A, Stephan A, Kamel G, Frem G, Younan F, Rizk S, Moubarak R, Karam A. Transplant Proc; 1996 Jun; 28(3):1318-20. PubMed ID: 8658676 [No Abstract] [Full Text] [Related]
38. Evaluation of the new cyclosporine formulation, Consupren, in renal transplant patients. Stephan AG, Barbari A, Masri MA, Rizk S, Moubarak R, Frem GJ, Kamel G, Baracat-Khoury W, Karam A. Transplant Proc; 1996 Jun; 28(3):1348-9. PubMed ID: 8658688 [No Abstract] [Full Text] [Related]